BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11769474)

  • 1. [Detection of PSA mRNA in prostate cancer patients' blood].
    Ito T; Okubo Y; Tachibana M
    Rinsho Byori; 2001 Oct; 49(10):974-7. PubMed ID: 11769474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [RT-PCR assay for detecting PSA mRNA in peripheral blood of prostate cancer patients].
    Okubo Y; Ito T
    Hinyokika Kiyo; 1999 Jan; 45(1):25-30. PubMed ID: 10086262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM
    Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
    Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
    Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
    Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.
    de Cremoux P; Ravery V; Podgorniak MP; Chevillard S; Toublanc M; Thiounn N; Tatoud R; Delmas V; Calvo T; Boccon-Gibod L
    Eur Urol; 1997; 32(1):69-74. PubMed ID: 9266235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
    Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
    Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
    Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
    Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
    Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH
    Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.
    Straub B; Müller M; Krause H; Goessl C; Schrader M; Heicappell R; Miller K
    Oncol Rep; 2002; 9(3):545-9. PubMed ID: 11956625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy.
    Tombal B; Van Cangh PJ; Loric S; Gala JL
    Prostate; 2003 Aug; 56(3):163-70. PubMed ID: 12772185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative PSA RT-PCR for preoperative staging of prostate cancer.
    Kurek R; Ylikoski A; Renneberg H; Konrad L; Aumüller G; Roddiger SJ; Zamboglou N; Tunn UW; Lilja H
    Prostate; 2003 Sep; 56(4):263-9. PubMed ID: 12858354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells.
    McIntyre IG; Spreckley K; Clarke RB; Anderson E; Clarke NW; George NJ
    Br J Cancer; 2000 Oct; 83(8):992-7. PubMed ID: 10993644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
    Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
    Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between reverse transcriptase-polymerase chain reaction for prostate specific antigen, survival, and various prognostic laboratory factors in patients with hormone refractory prostate cancer.
    Gandhok NK; Looney S; Koochekpour S; Sartor O
    Urol Oncol; 2005; 23(3):163-7. PubMed ID: 15907715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
    Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
    Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical surveillance after surgery for prostate cancer].
    Guercio S; Terrone C; Scarpa RM
    Recenti Prog Med; 2003 Mar; 94(3):110-3. PubMed ID: 12677777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of reverse transcriptase-polymerase chain reaction for staging patients with clinically localized prostate cancer.
    Nejat RJ; Katz AE; Olsson CA
    Semin Urol Oncol; 1998 Feb; 16(1):40-5. PubMed ID: 9508082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.